Literature DB >> 32210391

Does methotrexate improve TNF inhibitor drug survival in elderly patients with RA?

Clément Lahaye1,2, Martin Soubrier3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32210391     DOI： 10.1038/s41584-020-0411-7

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  2 in total

1.  EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2.

Authors:  Robert Bm Landewé; Pedro M Machado; Féline Kroon; Hans Wj Bijlsma; Gerd R Burmester; Loreto Carmona; Bernard Combe; Massimo Galli; Laure Gossec; Annamaria Iagnocco; John D Isaacs; Xavier Mariette; Iain McInnes; Ulf Mueller-Ladner; Peter Openshaw; Josef S Smolen; Tanja A Stamm; Dieter Wiek; Hendrik Schulze-Koops
Journal:  Ann Rheum Dis       Date:  2020-06-05       Impact factor: 27.973

2.  Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register.

Authors:  Katie Bechman; Anuoluwapo Oke; Mark Yates; Sam Norton; Elaine Dennison; Andrew P Cope; James B Galloway
Journal:  Rheumatology (Oxford)       Date:  2020-09-01       Impact factor: 7.580
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.